KEAP1 and diabetic kidney disease: However, in diabetic kidney disease (DKD) and CKD, which are characterized by proteinuria, the question of whether the activation of the Keap1-Nrf2 pathway can improve the prognosis of kidney function via direct effects on tubular protection has not been evaluated.